Objective: Implant-associated infections, including periprosthetic joint infection (PJI) and fracture-related infection (FRI), are among the most challenging complications in orthopedic surgery. Although infection timing (early, delayed, late) is recognized as an important factor in surgical success, its impact on patient-reported outcomes and length of hospital stay has rarely been compared between PJI and FRI in a single cohort. This study aimed to examine the association between infection timing and health-related quality of life (HRQoL) as well as length of hospital stay (LOS), and to explore potential differences between PJI and FRI.
Methods: We conducted a retrospective monocentric cohort study of 60 patients with microbiologically confirmed implant-associated infections treated at a German level-I trauma center between January and December 2021, with follow-up performed in 2023. Patients with PJI (n = 29) or FRI (n = 31) were stratified as early (< 3 months), delayed (3–24 months), or late (> 24 months) to enable direct comparison between infection entities. Outcomes included EQ-VAS, EQ-5D-3L mean domain scores, LOS, reinfection, revision surgery, amputation, and in-hospital mortality. Group differences were tested using independent-samples t-tests for continuous variables and chi-square or Fisher's exact tests for categorical variables, with subgroup analyses considered exploratory due to small sample sizes.
Results: Of the 60 patients, 25 had early (PJI n = 11; FRI n = 14), 24 delayed (PJI n = 11; FRI n = 13), and 11 late infections (PJI n = 7; FRI n = 4). EQ-VAS was higher in FRI compared with PJI in early (63.4 ± 17.8, n = 13 vs. 48.3 ± 20.8, n = 9) and delayed infections (66.2 ± 16.8, n = 11 vs. 56.6 ± 13.5, n = 10), while both groups showed markedly lower EQ-VAS values in late infections (FRI: 39.7 ± 25.9, n = 3 vs. PJI: 43.3 ± 23.4, n = 6), which were analyzed descriptively due to very small subgroup sizes. The EQ-5D-3L mean domain score was lower (indicating better health status) in early FRI (1.55 ± 0.33, n = 12) than in early PJI (1.91 ± 0.39, n = 9) in unadjusted analyses. LOS increased with timing, particularly in PJI (early 39.6 ± 26.8 vs. 31.4 ± 29.0 days; delayed 100.6 ± 82.2 vs. 28.2 ± 10.2; p = 0.015). Reinfection rates increased with later timing (early: 6/11 PJI vs. 3/14 FRI; delayed: 8/11 vs. 8/13; late: 5/7 vs. 4/4). Revision surgery was more frequent in early PJI (7/11 vs. 4/14; p = 0.080) but was significantly more common in delayed FRI (12/13 vs. 6/11; p = 0.033). Amputation (≤ 9%) and in-hospital mortality (≤ 15%) were rare and showed no significant differences.
Conclusions: Infection timing was associated with both clinical and patient-reported outcomes in implant-associated infections. Later infections were associated with poorer HRQoL, longer hospital stays, and higher reinfection rates, based on unadjusted analyses, with distinct patterns between PJI and FRI. Early recognition and timely, stage-adapted treatment strategies may help improve patient outcomes.
| [1] |
N. Walter, M. Rupp, S. Lang, and V. Alt, “The Epidemiology of Fracture-Related Infections in Germany,” Scientific Reports 11 (2021): 10443.
|
| [2] |
M. Rupp, N. Walter, S. Bärtl, R. Heyd, F. Hitzenbichler, and V. Alt, “Fracture-Related Infection- Epidemiology, Etiology, Diagnosis, Prevention, and Treatment,” Deutsches Ärzteblatt International 121 (2024): 17–24.
|
| [3] |
J. Iliaens, J. Onsea, H. Hoekstra, S. Nijs, W. E. Peetermans, and W. J. Metsemakers, “Fracture-Related Infection in Long Bone Fractures: A Comprehensive Analysis of the Economic Impact and Influence on Quality of Life,” Injury 52 (2021): 3344–3349.
|
| [4] |
A. A. Koutalos, C. Baltas, V. Akrivos, C. Arnaoutoglou, and K. N. Malizos, “Mortality, Functional Outcomes and Quality of Life After Hip Fractures Complicated by Infection: A Case Control Study,” Journal of Bone and Joint Infection 6 (2021): 347–354.
|
| [5] |
Y. Cai, H. Hu, Y. Chen, et al., “Staphylococcus aureus Manipulates Osteocytes to Cause Persistent Chronic Osteomyelitis and Antibiotic Resistance via Pyroptosis Pathway Suppression,” Drug Resistance Updates 84 (2026): 101295.
|
| [6] |
C. Li, N. Renz, A. Trampuz, and C. Ojeda-Thies, “Twenty Common Errors in the Diagnosis and Treatment of Periprosthetic Joint Infection,” International Orthopaedics 44 (2020): 3–14.
|
| [7] |
I. W. Kennedy and F. S. Haddad, “The Duration of Antibiotic Prophylaxis in Primary Hip and Knee Arthroplasty,” Bone & Joint Journal 107-B (2025): 858–861.
|
| [8] |
J. A. Browne, B. F. Sandberg, M. R. D'Apuzzo, and W. M. Novicoff, “Depression Is Associated With Early Postoperative Outcomes Following Total Joint Arthroplasty: A Nationwide Database Study,” Journal of Arthroplasty 29 (2014): 481–483.
|
| [9] |
N. Walter, M. Rupp, K. Hierl, et al., “Long-Term Patient-Related Quality of Life After Knee Periprosthetic Joint Infection,” Journal of Clinical Medicine 10 (2021): 907.
|
| [10] |
C. Knebel, J. Menzemer, F. Pohlig, et al., “Peri-Prosthetic Joint Infection of the Knee Causes High Levels of Psychosocial Distress: A Prospective Cohort Study,” Surgical Infections 21 (2020): 877–883.
|
| [11] |
V. T. Krenn, M. S. Bönigk, A. Trampuz, M. Liebisch, C. Perka, and S. Meller, “Coping With Chronic Periprosthetic Joint Infection After Failed Revision of Total Knee and Hip Arthroplasty: A Qualitative Study on Patient's Experiences in Treatment and Healing,” PLoS One 20 (2025): e0319509.
|
| [12] |
B. Wimalan, M. Rupp, V. Alt, and N. Walter, “The Patients' Perspective—A Qualitative Analysis of Experiencing a Fracture-Related Infection,” Frontiers in Psychology 14 (2023): 1126826.
|
| [13] |
N. Walter, M. Rupp, K. Hierl, et al., “Long-Term Patient-Related Quality of Life After Fracture-Related Infections of the Long Bones,” Bone & Joint Research 10 (2021): 321–327.
|
| [14] |
S. Y. He, B. Yu, and N. Jiang, “Current Concepts of Fracture-Related Infection,” International Journal of Clinical Practice 2023 (2023): 4839701.
|
| [15] |
M. A. S. Buijs, S. Haidari, F. F. A. IJpma, F. Hietbrink, and G. A. M. Govaert, “What Can They Expect? Decreased Quality of Life and Increased Postoperative Complication Rate in Patients With a Fracture-Related Infection,” Injury 55 (2024): 111425.
|
| [16] |
D. Cooper, E. Athan, P. Yates, C. Aboltins, J. S. Davis, and L. Manning, “How Much Does Prosthetic Joint Infection and Its Successful Treatment Affect Patient-Reported Quality of Life?,” Clinical Orthopaedics and Related Research 483 (2025): 183–193.
|
| [17] |
C. Zhang, Z. Liu, Y. Lin, et al., “Patient-Reported Outcome on Quality of Life and Pain After Revision Arthroplasty for Periprosthetic Joint Infection: A Cross-Sectional Study,” Journal of Clinical Medicine 11 (2022): 7182.
|
| [18] |
L. Rietbergen, J. W. P. Kuiper, S. Walgrave, L. Hak, and S. Colen, “Quality of Life After Staged Revision for Infected Total Hip Arthroplasty: A Systematic Review,” Hip International 26 (2016): 311–318.
|
| [19] |
A. Unsworth, B. Young, M. Scarborough, and M. McNally, “A Comparison of Causative Pathogens in Bone and Prosthetic Joint Infections: Implications for Antimicrobial Therapy,” Antibiotics 13 (2024): 1125.
|
| [20] |
J. Moock, “Präferenzbasierte Lebensqualitätsmessung: Der EQ-5D Fragebogen,” Physikalische Medizin, Rehabilitationsmedizin, Kurortmedizin 18 (2008): 245–249.
|
| [21] |
A. Hinz, T. Kohlmann, Y. Stöbel-Richter, M. Zenger, and E. Brähler, “The Quality of Life Questionnaire EQ-5D-5L: Psychometric Properties and Normative Values for the General German Population,” Quality of Life Research 23 (2014): 443–447.
|
| [22] |
K. Borchert, C. Jacob, N. Wetzel, et al., “Application Study of the EQ-5D-5L in Oncology: Linking Self-Reported Quality of Life of Patients With Advanced or Metastatic Colorectal Cancer to Clinical Data From a German Tumor Registry,” Health Economics Review 10 (2020): 1–14.
|
| [23] |
W. Zimmerli, A. Trampuz, and P. E. Ochsner, “Prosthetic-Joint Infections,” New England Journal of Medicine 351 (2004): 351–1654, https://doi.org/10.1056/NEJMRA040181.
|
| [24] |
C. A. M. Löwik, J. Parvizi, P. C. Jutte, et al., “Debridement, Antibiotics, and Implant Retention Is a Viable Treatment Option for Early Periprosthetic Joint Infection Presenting More Than 4 Weeks After Index Arthroplasty,” Clinical Infectious Diseases 71 (2020): 630–636.
|
| [25] |
S. B. Morgan, G. German, H. Abdelbary, G. Grammatopoulos, and S. Garceau, “Timing From Admission to Debridement, Antibiotics, and Implant Retention Affects Treatment Success in Total Knee Arthroplasty Periprosthetic Joint Infection,” Journal of Arthroplasty 41 (2025): 39–46, https://doi.org/10.1016/J.ARTH.2025.06.042.
|
| [26] |
R. Kuehl, S. Tschudin-Sutter, M. Morgenstern, et al., “Time-Dependent Differences in Management and Microbiology of Orthopaedic Internal Fixation-Associated Infections: An Observational Prospective Study With 229 Patients,” Clinical Microbiology and Infection 25 (2019): 76–81.
|
| [27] |
M. Morgenstern, R. Kuehl, C. G. Zalavras, et al., “The Influence of Duration of Infection on Outcome of Debridement and Implant Retention in Fracture-Related Infection,” Bone & Joint Journal 103-B (2021): 213–221.
|
| [28] |
J. Parvizi, T. Gehrke, and A. F. Chen, “Proceedings of the International Consensus on Periprosthetic Joint Infection,” Bone & Joint Journal 95-B (2013): 1450–1452.
|
| [29] |
I. K. Sigmund, M. Luger, R. Windhager, and M. A. McNally, “Diagnosing Periprosthetic Joint Infections: A Comparison of Infection Definitions: EBJIS 2021, ICM 2018, and IDSA 2013,” Bone & Joint Research 11 (2022): 608–618.
|
| [30] |
M. McNally, R. Sousa, M. Wouthuyzen-Bakker, et al., “The EBJIS Definition of Periprosthetic Joint Infection,” Bone & Joint Journal 103-B (2021): 18–25.
|
| [31] |
P. Izakovicova, O. Borens, and A. Trampuz, “Periprosthetic Joint Infection: Current Concepts and Outlook,” EFORT Open Reviews 4 (2019): 482–494.
|
| [32] |
X. Jin, B. Gallego Luxan, M. Hanly, et al., “Estimating Incidence Rates of Periprosthetic Joint Infection After Hip and Knee Arthroplasty for Osteoarthritis Using Linked Registry and Administrative Health Data,” Bone & Joint Journal 104-B (2022): 1060–1066.
|
| [33] |
V. Alt, M. McNally, M. Wouthuyzen-Bakker, et al., “The FRI Classification—A New Classification of Fracture-Related Infections,” Injury 55, no. 11 (2024): 111831, https://doi.org/10.1016/J.INJURY.2024.111831.
|
| [34] |
L. E. Streck, C. M. Sterneder, L. Haralambiev, M. Brenneis, Y. F. Chiu, and F. Boettner, “Significant Differences in the Rate of Periprosthetic Joint Infections in Revision Hip and Knee Arthroplasty Depending on the Applied Definition,” Archives of Orthopaedic and Trauma Surgery 145 (2025): 1–9.
|
| [35] |
R. Osinga, M. M. Eggimann, S. J. Lo, et al., “Orthoplastics in Periprosthetic Joint Infection of the Knee: Treatment Concept for Composite Soft-Tissue Defect With Extensor Apparatus Deficiency,” Journal of Bone and Joint Infection 5 (2020): 160–171.
|
| [36] |
T. F. Moriarty, G. Muthukrishnan, J. L. Daiss, et al., “Bone Infection: A Clinical Priority for Clinicians, Scientists and Educators,” European Cells & Materials 42 (2021): 312–333.
|
| [37] |
J. Frese, L. Schwake, A. P. Schulz, S. Schaeffer, U. J. Gerlach, and C. Grimme, “Life After Bone Infection: A Retrospective Comparison of Quality of Life in Patients With Periprosthetic Joint Infection and Fracture-Related Infections,” Journal of Orthopaedic Surgery and Research 20 (2025): 1012, https://doi.org/10.1186/s13018-025-06427-2.
|
| [38] |
D. Graan and Z. J. Balogh, “Microbiology of Fracture Related Infections,” Journal of Orthopaedic Surgery (Hong Kong) 30, no. 3 (2022): 10225536221118512, https://doi.org/10.1177/10225536221118512.
|
| [39] |
E. K. Tissingh, L. Marais, A. Loro, et al., “Management of Fracture-Related Infection in Low Resource Settings: How Applicable Are the Current Consensus Guidelines?,” EFORT Open Reviews 7 (2022): 422–432.
|
| [40] |
R. Kumar, S. Basu, D. Torigian, V. Anand, H. Zhuang, and A. Alavi, “Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography,” Clinical Microbiology Reviews 21 (2008): 209–224.
|
RIGHTS & PERMISSIONS
2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
(439KB)
